Sign in

CIK 0001661181

  • Accelerated filer

Organogenesis Holdings Inc.

Sign in to watch
Ticker
ORGO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-575-0775
Business address
85 DAN ROAD, CANTON, MA, 02021
Former names
Avista Healthcare Public Acquisition Corp.
  1. 4 Shares withheld for taxes VP and General Counsel gave up 1,975 shares (to pay taxes)
  2. 4 Shares withheld for taxes President and CEO gave up 6,265 shares (to pay taxes)
  3. 4 Shares withheld for taxes VP Health Policy & Contracting gave up 1,770 shares (to pay taxes)
  4. 4 Grant or award Chief Financial Officer acquired 10,965 shares (grant or award)
  5. 4 Grant or award VP Health Policy & Contracting acquired 8,260 shares (grant or award)
  6. 4 Grant or award Chief Commercial Officer acquired 10,782 shares (grant or award)
  7. 4 Grant or award VP and General Counsel acquired 8,808 shares (grant or award)
  8. 4 Grant or award Chief Operating Officer acquired 10,782 shares (grant or award)
  9. 4 Open-market sale President and CEO sold 106,038 shares at an average $13.28 ($1,408,618)
  10. 4 Grant or award Director acquired 11,800 shares (grant or award)
  11. 4 Grant or award Director acquired 11,800 shares (grant or award)
  12. 4 Grant or award Director acquired 11,800 shares (grant or award)
  13. 4 Grant or award Chief Financial Officer acquired 5,396 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale President and CEO sold 291,862 shares at an average $13.32 ($3,886,852)
  16. 4 Open-market sale Director sold 200,000 shares at $3.25 ($650,000)
  17. 4 Open-market sale Director sold 200,000 shares at $3.25 ($650,000)
  18. 5 Insider Annual Insider Trading Report
  19. 5 Insider Annual Insider Trading Report
  20. 4 Grant or award Interim CFO acquired 10,700 shares (grant or award)

Page 11 of 17 · 321 filings